The emergence of targeted therapies and precision medicine in the radiotherapy market has marked a paradigm shift in cancer treatment. These innovative approaches have paved the way for more effective and personalized treatments, significantly improving patient outcomes and quality of life. By leveraging advanced molecular and genetic knowledge, targeted therapies have redefined how radiotherapy is delivered, making it more precise and tailored to individual patients.
Market Overview:
The global Radiotherapy Market is estimated to be valued at US$ 7,078.91 million in 2022 and is expected to exhibit a CAGR of 6.8% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights. Radiotherapy refers to the use of high-energy radiation to destroy cancer cells and shrink tumors. The advantages of radiotherapy include targeted treatment, minimal ... Read more
